Insight journal - Therapy

Dermatology partnering – recent deals analysis 2009-2014

Posted on 23 July 2014

Tags: , ,

Partnering in the last decade has seen an increase in dermatology with an rise specifically in modern diagnostic technologies.

Dermatology is a branch of science that deals with skin, nails, hair and its diseases.  According to the Current Agreements, dermatology partnering has been an upcoming  therapeutic area for licensing, distribution and marketing deal making among pharmaceutical and biotech industries.

The data in this article has been sourced from the newly published Dermatology Partnering Terms and Agreements report.

The following figure shows dermatology partnering frequency between 2009 and mid July 2014.

Figure 1: Dermatology partnering since 2009

 

derm1Source: Current Agreements, 2014

It is evident that partnering activity is high in number in the past five years with an average of 138 deals since 2009. The graph above shows 180 deals announced in the year 2010 alone.

According to Current Agreements, pharmaceuticals companies are very active in dermatology dealmaking followed by biotech, consumer health and medical devices industry sectors.

The following figure provides an overview of dermatology partnering by major industry sector since 2009

Figure 2: Dermatology partnering by industry sector since 2009

 

derm2

 

 

 

 

 

 

 

 

 

 

 

 

 

Source: Current Agreements, 2014

Dermatology partnering is often targeted towards one of more specific dermatology indications. Some of the popular and commonly partnered dermatology therapeutics indications are cosmetics and wound healing.

An example to cite would be the recent deal where Allergan and Medytox entered into a licensing agreement to develop neurotoxin product candidates used in cosmetics. The deal worth $362 million comprised of upfront payment by Allergan and certain development milestones .…click here for more on this deal

The following figure illustrates all the individual dermatology therapeutic indications recorded in our database.

Figure 3: Dermatology partnering by individual therapeutics area since 2009

 

derm3Source: Current Agreements, 2014

Analysis from our Current Agreements database, suggests that the vast majority or deals are made at the marketed stage.

Figure 4: Dermatology partnering by stage of development since 2009

 

derm4

 

 

 

 

 

 

 

Source: Current Agreements, 2014

Dermatology, being an upcoming and thriving area for deal making, can have a high headline deal value.

The following figure shows the leading dermatology deals by headline value of the deal when announced between 2009 and mid July 2014. The list id unsurprisingly dominated by big pharma companies.

 Figure 4: Top Dermatology deals by value since 2009

 

derm5

 

 

 

 

 

 

 

 

 

 

 

Source: Current Agreements, 2014

A useful means of understanding best practice in dermatology dealmaking is to follow the activities and deal terms used by the most active companies in a certain type of deal.

The following is a list of the most active dermatology dealmakers since 2009. Moberg Pharma, a Swedish company, tops the list with 19 deals announced since 2009.

Figure 6: Most active Dermatology  dealmakers  since 2009

derm6Source: Current Agreements, 2014

 

The Dermatology Partnering Terms and Agreements report published by Current Partnering provides full details of over 650 dermatology deals announced since 2009 and includes average deal terms including headline, upfront, milestone and royalty rates, where available. In addition, the report provides details of deals broken down by deal type, stage of development; company A-Z, specific individual therapy area and technology type. More details here

There is a huge expectation and active deal making seen in the dermatology sector creating an interesting environment for research and development in this area

 

Sources

The above information has been abstracted from the following resources:

Shamini Thiagarajan

 

Related

Read: more dermatology deals in pharma, biotech, life science partnering deal news, insights and glossary

View: glossary definition for dermatology partnering

ReportDermatology Partnering Terms and Agreements

View also: Other specific dermatology indication reports

View: Current Partnering’s Partnering Scorecard – view top life science partnering deals by value

View: Current Partnering’s Deal Metrics – the latest deal trend infographics for life science deal making

Signup: Current Partnering Dealmakers Update – weekly newsletter providing the latest life science industry deal news, deal making trends, partnering events – sign up now

Signup: Current Agreements Deals Review – monthly newsletter – reviewing the previous month’s life science deal making – partnering, M&A and financing – sign up now

Subscribe: Current Agreements life sciences partnering, M&A and financing deals database – find out more

Follow us on: LinkedIn Current Partnering | LinkedIn Business Development Network | @Currentpartner on Twitter

 

Print Friendly, PDF & Email

Leave a Reply